Precision Medicine to Redefine Insulin Secretion and Monogenic Diabetes-Randomized Controlled Trial (PRISM-RCT)
Highlights of the Study
We designed a patient-centered care model to evaluate its impact on clinical outcomes in young-onset type 2 diabetes patients.
Research Design and Methods
The trial evaluates a multicomponent care model using technology, biogenetic markers, and patient-reported outcomes in patients diagnosed with type 2 diabetes at a young age.
Results
884 patients were assigned to receive specialist-led team-based management or usual care. The study identified various health profiles and comorbidities among the patients, highlighting the complexity of young-onset diabetes.
Conclusions
The study shows that young-onset diabetes is characterized by complex etiologies with comorbidities including mental illness and lifecourse events.
Trial Registration
Trial registration number: NCT04049149
Clinical Trials and Practical Solutions
Clinical trials are crucial for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates standards, protocols, and research for easy access by clinicians.
Value of Streamlining Operations
In today’s healthcare environment, streamlining operations is crucial. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally.
Enhancing Workflows with AI
AI can enhance clinic workflows and improve patient outcomes, reducing paper routines. Learn more about how we can help at aidevmd.com.
